Stock Events

Stock Events

Dermapharm 

€43.75
0
+€1.05+2.46% Friday 17:01

Statistics

Day High
43.8
Day Low
43.7
52W High
-
52W Low
-
Volume
225
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q4 2025
Next
0.41
0.51
0.6
0.7
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DMP.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, competing with Dermapharm in various therapeutic areas.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Dermapharm's offerings in the healthcare market.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a leading pharmaceutical company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Dermapharm in several areas.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a global healthcare company that produces pharmaceuticals and vaccines, directly competing with Dermapharm in the healthcare and pharmaceutical sectors.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson is a diversified healthcare company that produces pharmaceuticals, medical devices, and consumer health products, competing with Dermapharm across multiple segments.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global biopharmaceutical company focused on human health, directly competing with Dermapharm in the pharmaceutical and healthcare sectors.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie is a biopharmaceutical company that develops and markets therapies focused on treating serious medical conditions, competing with Dermapharm in the healthcare sector.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG is a healthcare company that operates in pharmaceuticals and diagnostics, competing with Dermapharm in the development and marketing of pharmaceutical products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty medicines, competing with Dermapharm in the generic pharmaceuticals market.

About

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Show more...
CEO
Dr. Hans-Georg Feldmeier
Employees
3610
Country
GB
ISIN
DE000A2GS5D8

Listings

STU
DE
DMP.STU
VI
AT
DMP.VI
LSE
GB
0A5J.LSE
XETRA
DE
DMP.XETRA

0 Comments

Share your thoughts

FAQ

What is Dermapharm stock price today?▼
The current price of DMP.STU is €43.75 EUR — it has increased by +2.46% in the past 24 hours. Watch Dermapharm stock price performance more closely on the chart.
What is Dermapharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dermapharm stocks are traded under the ticker DMP.STU.
Is Dermapharm stock price growing?▼
DMP.STU stock has fallen by -5.91% compared to the previous week, the month change is a +7.89% rise, over the last year Dermapharm has showed a +19.7% increase.
When is the next Dermapharm earnings date?▼
Dermapharm is going to release the next earnings report on May 13, 2026.
What were Dermapharm earnings last quarter?▼
DMP.STU earnings for the last quarter are 0.7 EUR per share, whereas the estimation was 0.41 EUR resulting in a +68.29% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Dermapharm have?▼
As of April 11, 2026, the company has 3,610 employees.
When did Dermapharm complete a stock split?▼
Dermapharm has not had any recent stock splits.
Where is Dermapharm headquartered?▼
Dermapharm is headquartered in Grünwald, GB.